Skip to main content

Table 4 Vaccination rates for PCV13 and PPSV23 overall and by intervention group within the adult populations studied

From: Impact of a guideline-based best practice alert on pneumococcal vaccination rates in adults in a primary care setting

Vaccination Rates Family Med Clinics (A) Family Med Clinics (B) Internal Med Clinics (C)
Baseline Interim Follow-up p-value Baseline Interim Follow-up p-value Baseline Interim Follow-up p-value
High risk adults aged 19–64 years
 PCV13 eligible 691 961 994   732 982 1088   1030 1369 1308  
  Vaccinated (n) 14 117 199 <.0001 17 135 261 <.0001 30 247 363 <.0001
  Vaccinated (%) 2.03 12.17 20.02   2.32 13.75 23.99   2.91 18.04 27.75  
 PPSV23 eligible 734 1000 1048   785 1024 1139   1125 1395 1393  
  Vaccinated (n) 146 278 302 <.0001 182 260 351 0.0004 317 427 491 0.0005
  Vaccinated (%) 19.89 27.80 28.82   23.18 25.39 30.82   28.18 30.61 35.25  
Immunocompetent adults aged 65+
 PCV13 eligible   2429 2807    2966 3724    5403 5530 <.0001
  Vaccinated (n) NA 997 1677    971 2177    2842 3778  
Vaccinated (%) NA 41.05 59.74    32.74 58.46    52.60 68.32  
 PPSV23 eligible 2162 1796 2167   2519 2360 2683   4799 3519 4687  
  Vaccinated (n) 1368 981 1219 <.0001 1356 1196 1301 0.001 3253 1999 3017 <.0001
  Vaccinated (%) 63.27 54.62 56.25   53.83 50.68 48.49   67.78 56.81 64.37  
Immunocompromised Adults Aged 65+
 PCV13 eligible 453 578 600   452 619 684   1374 1878 1777  
  Vaccinated (n) 2 248 416 <.0001 4 239 440 <.0001 9 1091 1323 <.0001
  Vaccinated (%) 0.44 42.91 69.33   0.88 38.61 64.33   0.66 58.09 74.45  
 PPSV23 eligible 516 589 637   512 642 742   1549 1894 1907  
  Vaccinated (n) 369 391 434 0.180 327 416 492 0.6559 1144 1303 1397 0.0011
  Vaccinated (%) 71.51 66.38 68.13   63.87 64.8 66.31   73.85 68.8 73.26  
  1. Bold text indicates statistical significance
\